U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Books

Items: 1 to 20 of 35

1.
STOP 301: A Phase 3, open‐label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD®) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients
Timothy R. Smith, Paul Winner, Sheena K. Aurora, Maria Jeleva, Jasna Hocevar‐Trnka, Stephen B. Shrewsbury
Headache. 2021 Sep; 61(8): 1214–1226. Published online 2021 Aug 7. doi: 10.1111/head.14184
PMCID:
PMC9292844
ArticlePDF–804K
2.
Imaging the Premonitory Phase of Migraine
Nazia Karsan, Peter J. Goadsby
Front Neurol. 2020; 11: 140. Published online 2020 Mar 25. doi: 10.3389/fneur.2020.00140
PMCID:
PMC7109292
ArticlePDF–610K
3.
Efficacy, Tolerability, and Safety of DFN‐15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study
Richard B. Lipton, Sagar Munjal, Elimor Brand‐Schieber, Stewart J. Tepper, David W. Dodick
Headache. 2020 Jan; 60(1): 58–70. Published online 2019 Oct 24. doi: 10.1111/head.13663
PMCID:
PMC7003821
ArticlePDF–177K
4.
Mechanisms of migraine as a chronic evolutive condition
Anna P. Andreou, Lars Edvinsson
J Headache Pain. 2019; 20(1): 117. Published online 2019 Dec 23. doi: 10.1186/s10194-019-1066-0
PMCID:
PMC6929435
ArticlePDF–1.1M
5.
PACAP and Other Neuropeptide Targets Link Chronic Migraine and Opioid-induced Hyperalgesia in Mouse Models*
Krishna D.B. Anapindi, Ning Yang, Elena V. Romanova, Stanislav S. Rubakhin, Alycia Tipton, Isaac Dripps, Zoie Sheets, Jonathan V. Sweedler, Amynah A. Pradhan
Mol Cell Proteomics. 2019 Dec; 18(12): 2447–2458. Published online 2020 Oct 10. doi: 10.1074/mcp.RA119.001767
PMCID:
PMC6885698
ArticlePDF–1.7M
6.
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial
Richard B. Lipton, David W. Dodick, Jessica Ailani, Kaifeng Lu, Michelle Finnegan, Armin Szegedi, Joel M. Trugman
JAMA. 2019 Nov 19; 322(19): 1887–1898. Published online 2019 Nov 19. doi: 10.1001/jama.2019.16711
Correction in:
JAMA. 2020 Apr 7; 323(13): 1318.
PMCID:
PMC6865323
Article
7.
Roles of Inflammation, Neurogenic inflammation, and Neuroinflammation in Pain
Megumi Matsuda, Yul Huh, Ru-Rong Ji
J Anesth. Author manuscript; available in PMC 2019 Oct 25.
Published in final edited form as: J Anesth. 2019 Feb; 33(1): 131–139. Published online 2018 Nov 17. doi: 10.1007/s00540-018-2579-4
PMCID:
PMC6813778
ArticlePDF–543K
8.
Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia
Joan Crespi, Daniel Bratbak, David W. Dodick, Manjit Matharu, Kent Are Jamtøy, Erling Tronvik
Headache. 2019 Sep; 59(8): 1229–1239. Published online 2019 Jul 25. doi: 10.1111/head.13608
PMCID:
PMC6771650
ArticlePDF–187K
9.
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial
David Yarnitsky, David W. Dodick, Brian M. Grosberg, Rami Burstein, Alon Ironi, Dagan Harris, Tamar Lin, Stephen D. Silberstein
Headache. 2019 Sep; 59(8): 1240–1252. Published online 2019 May 9. doi: 10.1111/head.13551
PMCID:
PMC6767146
ArticlePDF–517K
10.
Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications
Alan M. Rapoport, Jo H. Bonner, Tamar Lin, Dagan Harris, Yaron Gruper, Alon Ironi, Robert P. Cowan
J Headache Pain. 2019; 20(1): 83. Published online 2019 Jul 22. doi: 10.1186/s10194-019-1033-9
PMCID:
PMC6734294
ArticlePDF–855K
11.
Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs
Jakob Møller Hansen, Andrew Charles
J Headache Pain. 2019; 20(1): 96. Published online 2019 Sep 6. doi: 10.1186/s10194-019-1046-4
PMCID:
PMC6734209
ArticlePDF–761K
12.
Symptoms related to the visual system in migraine
Robin M. van Dongen, Joost Haan
Version 1. F1000Res. 2019; 8: F1000 Faculty Rev-1219. Published online 2019 Jul 30. doi: 10.12688/f1000research.18768.1
PMCID:
PMC6668047
ArticlePDF–3.4M
13.
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Peter J Goadsby, Linda A Wietecha, Ellen B Dennehy, Bernice Kuca, Michael G Case, Sheena K Aurora, Charly Gaul
Brain. 2019 Jul; 142(7): 1894–1904. Published online 2019 May 27. doi: 10.1093/brain/awz134
PMCID:
PMC6620826
ArticlePDF–391K
14.
CGRP and the Trigeminal System in Migraine
Smriti Iyengar, Kirk W. Johnson, Michael H. Ossipov, Sheena K. Aurora
Headache. 2019 May; 59(5): 659–681. Published online 2019 Apr 14. doi: 10.1111/head.13529
PMCID:
PMC6593989
ArticlePDF–395K
15.
Effectiveness of the Concurrent Intravenous Injection of Dexamethasone and Metoclopramide for Pain Management in Patients with Primary Headaches Presenting to Emergency Department
Sahar Mirbaha, Hossein Delavar-Kasmaei, Erfan Erfan
Adv J Emerg Med. 2017 Autumn; 1(1): e6. Published online 2017 Oct 12. doi: 10.22114/AJEM.v1i1.12
PMCID:
PMC6548094
ArticlePDF–1.0M
16.
Sumatriptan (all routes of administration) for acute migraine attacks in adults ‐ overview of Cochrane reviews
Christopher J Derry, Sheena Derry, R Andrew Moore, Cochrane Pain, Palliative and Supportive Care Group
Cochrane Database Syst Rev. 2014; 2014(5): CD009108. Published online 2014 May 27. doi: 10.1002/14651858.CD009108.pub2
PMCID:
PMC6469574
ArticlePDF–597K
17.
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults
Philip J Wiffen, Roger Knaggs, Sheena Derry, Peter Cole, Tudor Phillips, R Andrew Moore, Cochrane Pain, Palliative and Supportive Care Group
Cochrane Database Syst Rev. 2016 Dec; 2016(12): CD012227. Published online 2016 Dec 27. doi: 10.1002/14651858.CD012227.pub2
PMCID:
PMC6463878
ArticlePDF–351K
18.
Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial
Denise E Chou, Marianna Shnayderman Yugrakh, Dana Winegarner, Vernon Rowe, Deena Kuruvilla, Jean Schoenen
Cephalalgia. 2019 Jan; 39(1): 3–14. Published online 2018 Nov 17. doi: 10.1177/0333102418811573
PMCID:
PMC6348457
ArticlePDF–585K
19.
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
Bernice Kuca, Stephen D. Silberstein, Linda Wietecha, Paul H. Berg, Gregory Dozier, Richard B. Lipton, on behalf of the COL MIG-301 Study Group
Neurology. 2018 Dec 11; 91(24): e2222–e2232. doi: 10.1212/WNL.0000000000006641
PMCID:
PMC6329326
ArticlePDF–600K
20.
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
GBD 2016 Headache Collaborators
Lancet Neurol. 2018 Nov; 17(11): 954–976. doi: 10.1016/S1474-4422(18)30322-3
Correction in:
Lancet Neurol. 2021 Dec; 20(12): e7.
PMCID:
PMC6191530
ArticlePDF–12M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center